Your browser doesn't support javascript.
loading
Enhancing Sleep Quality: Assessing the Efficacy of a Fixed Combination of Linden, Hawthorn, Vitamin B1, and Melatonin.
De Simone, Matteo; De Feo, Rosario; Choucha, Anis; Ciaglia, Elena; Fezeu, Francis.
Affiliation
  • De Simone M; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via Salvatore Allende, 84081 Baronissi, Italy.
  • De Feo R; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via Salvatore Allende, 84081 Baronissi, Italy.
  • Choucha A; Department of Neurosurgery, Aix Marseille University, APHM, UH Timone, 13005 Marseille, France.
  • Ciaglia E; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Via Salvatore Allende, 84081 Baronissi, Italy.
  • Fezeu F; Department of Neurology & Neurological Surgery, Brain Global, 27659 Arabian Drive, Salisbury, MD 21801, USA.
Med Sci (Basel) ; 12(1)2023 12 28.
Article de En | MEDLINE | ID: mdl-38249078
ABSTRACT
Sleep is essential for overall health, yet various sleep disorders disrupt normal sleep patterns, affecting duration, quality, and timing. This pilot study investigate the impact of a food supplement (SPINOFF®) on both sleep quality and mental well-being in 41 participants (mean age 45.3 years). Initial assessments revealed sleep disturbances (Pittsburgh Sleep Quality Index-PSQ-mean score 8.2) and insomnia symptoms (Insomnia Severity Index-ISI- mean score 12.7). Mental health assessments showed psychological distress (Dass-21 Depression mean score 4.2, Anxiety mean score 6.9, Stress mean score 11.6, Total mean score 22.7). This study assessed sleep continuity using Awakenings per Night (ApN) via a smartwatch (HELO HEALTH®) and conducted the study in two phases baseline (T0) and after 30 days of treatment (T1) (Phase A). No placebo-control was used in this study. After 30 days (Phase B), 21 patients were selected for reassessment. Eleven continued treatment for another 30 days (T2), while ten discontinued. Following the intervention, we observed remarkable improvements in sleep quality and mental distress. The SPINOFF® supplement significantly reduced the PSQI scores (22.4%), indicating enhanced sleep quality. Additionally, there was a 19.6% decrease in ISI scores, demonstrating a reduction in insomnia symptoms. Moreover, overall psychological distress decreased by 19.5% signifying improved psychological well-being. In the second phase, participants who continued treatment experienced more substantial improvements, with a mean decrease of 0.8 points in PSQI scores (±0.9) and a mean decrease of 0.9 points in ISI scores. Our findings suggest that the SPINOFF® supplement has the potential to effectively address both sleep disturbances and psychological distress in our study population.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Crataegus / Troubles de l'endormissement et du maintien du sommeil / Mélatonine Type d'étude: Clinical_trials Limites: Humans / Middle aged Langue: En Journal: Med Sci (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Crataegus / Troubles de l'endormissement et du maintien du sommeil / Mélatonine Type d'étude: Clinical_trials Limites: Humans / Middle aged Langue: En Journal: Med Sci (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Italie